Market Tracker

02/22 3:05am ET

Inovio Pharmaceuticals Inc (NASDAQ:INO)

6.80
Delayed Data
As of Feb 21
 -0.16 / -2.30%
Today’s Change
5.85
Today|||52-Week Range
11.69
-2.02%
Year-to-Date
Better Buy: Novavax, Inc. vs. Inovio Pharmaceuticals
Feb 16 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close6.96
Today’s open6.96
Day’s range6.79 - 6.99
Volume638,549
Average volume (3 months)975,360
Market cap$515.5M
Dividend yield--
Data as of 4:00pm ET, 02/21/2017

Growth & Valuation

Earnings growth (last year)+31.25%
Earnings growth (this year)--
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+288.00%
P/E ratioNM
Price/Sales11.32
Price/Book2.86

Competitors

 Today’s
change
Today’s
% change
RETAReata Pharmaceutical...-0.11-0.47%
SCLNSciClone Pharmaceuti...+0.20+2.05%
KERXKeryx Biopharmaceuti...-0.07-1.38%
RARXRa Pharmaceuticals I...+0.67+3.08%
Data as of 4:00pm ET, 02/21/2017

Financials

Next reporting dateMarch 20, 2017
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$40.6M
Annual profit (last year)-$29.2M
Net profit margin-71.94%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
J. Joseph Kim
Chief Operating Officer
Niranjan Y. Sardesai
Corporate headquarters
Plymouth Meeting, Pennsylvania

Forecasts